newsfilter
← Latest News
PR Newswire·

CANNTAB ANNOUNCES APPOINTMENT OF RICHARD GOLDSTEIN AS INTERIM CEO

TORONTO, Aug. 2, 2022 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL)(OTCQB:CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic application, announces that i